Trial Profile
Phase I pharmacokinetic and safety trial of intravenous gallium citrate in cystic fibrosis patients
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 May 2013
Price :
$35
*
At a glance
- Drugs Gallium citrate (Primary)
- Indications Cystic fibrosis-associated respiratory tract infections; Gram-negative infections; Gram-positive infections; Pseudomonal infections
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 28 May 2013 New trial record